Psychiatric Adverse Effects of Levetiracetam in Malignant Glioma Populations; a Retrospective Cohort Study
Objective: Levetiracetam is commonly used in malignant glioma populations because of its efficacy, limited drug-drug interactions and adverse effects. Although, there has been growing evidence of adverse neuropsychiatric side effects from levetiracetam; however, such evidence in malignant brain tumo...
Guardado en:
Autores principales: | Paul Thisayakorn, Isabel Schuermeyer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Prince of Songkla University
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2719ee7b09eb47e882fdd9822721fa80 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of Levetiracetam in Epileptic Dogs with Chronic Kidney Disease: A Retrospective Study
por: So-Yeon Gim, et al.
Publicado: (2021) -
Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review
por: Renly Lim, et al.
Publicado: (2021) -
Adverse drug reactions
por: AA Moghadam Nia
Publicado: (1999) -
Trametinib and dabrafenib induced rhabdomyolysis, renal failure, and visual loss. Report of one case
por: Finsterer,Josef
Publicado: (2020) -
Impacto clínico de un sistema de farmacovigilancia activa realizado por un farmacéutico en el reporte y subnotificación de reacciones adversas a medicamentos
por: Sánchez,Ignacio, et al.
Publicado: (2014)